Canada - anglais - Health Canada

pharmascience inc - selegiline hydrochloride - tablet - 5mg - selegiline hydrochloride 5mg - monoamine oxidase b inhibitors

Canada - anglais - Health Canada

pharmel inc - selegiline hydrochloride - tablet - 5mg - selegiline hydrochloride 5mg - monoamine oxidase b inhibitors

Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceva santé animale - selegiline hydrochloride 20 mg - eq. selegiline 16.74 mg - film-coated tablet - 20 mg - selegiline hydrochloride 20 mg - selegiline - dog

États-Unis - anglais - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - dexmethylphenidate hydrochloride (unii: 1678ok0e08) (dexmethylphenidate - unii:m32rh9mfgp) - dexmethylphenidate hydrochloride 2.5 mg - dexmethylphenidate hydrochloride tablets are indicated for the treatment of attention deficit hyperactivity disorder (adhd) [see clinical studies (14)]. - hypersensitivity to methylphenidate or other components of dexmethylphenidate hydrochloride tablets. hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with methylphenidate [see adverse reactions (6.1)] . - concomitant treatment with monoamine oxidase inhibitors (maois), or within 14 days following discontinuation of treatment with an moai, because of the risk of hypertensive crises [see drug interactions (7.1)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to adhd medications, including dexmethylphenidate hydrochloride tablets, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for adhd medications at 1-866-961-2388 or visit https://womensmentalhealth.org/adh

Australie - anglais - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - selegiline hydrochloride -

Australie - anglais - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - selegiline hydrochloride -

Japon - anglais - すりの適正使用協議会 RAD-AR Council, Japan

teva takeda pharma ltd. - selegiline hydrochloride - white tablet, diameter: 6.5 mm, thickness: 2.7 mm

Irlande - anglais - HPRA (Health Products Regulatory Authority)

orion corporation - selegiline hydrochloride - tablet - 5 milligram(s) - monoamine oxidase b inhibitors; selegiline

Israël - anglais - Ministry of Health

cts chemical industries ltd, israel - selegiline hydrochloride - tablets - selegiline hydrochloride 5 mg - selegiline - selegiline - treatment of parkinson's disease or symptomatic parkinsonism.

Irlande - anglais - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - selegiline hydrochloride - tablet - 5 milligram(s) - monoamine oxidase b inhibitors; selegiline